P1119: the oral pi3kδ inhibitor linperlisib for the treatment of relapsed or refractory follicular lymphoma: a single-arm multicenter phase 2 clinical trial

T. wang, X. sun, L. qiu, H. su, J. cao,Z. li, Y. song, L. zhang, S. yi, L. qiu, J. zhou, H. wu,W. zhang, J. li, K. zhou, H. zhou, Y. yang,Z. li, H. cen, Z. cai,Z. zhang, W. fu, J. jin, F. li,W. wu, X. gu, W. zhu,L. liu,Z. li

HemaSphere(2022)

引用 0|浏览0
暂无评分
关键词
oral pi3kδ inhibitor linperlisib,refractory follicular lymphoma,single-arm
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要